Mojtahed SA, Boyer NR, Rao SA, Gajewski TF, et al. Cost-Effectiveness Analysis of Adjuvant Therapy for BRAF-Mutant Resected Stage III Melanoma in Medicare Patients. Ann Surg Oncol 2021 Jun 15. pii: 10.1245/s10434-021-10288.
PMID: 34129153